Author:
Bruce Michael G.,Singleton Rosalyn,Bulkow Lisa,Rudolph Karen,Zulz Tammy,Gounder Prabhu,Hurlburt Debby,Bruden Dana,Hennessy Thomas
Funder
Centers for Disease Control and Prevention
Pfizer
CDC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference32 articles.
1. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study;Whitney;Lancet,2006
2. National Notifiable Diseases Surveillance System. Available from: http://wwwn.cdc.gov/nndss/; 2015.
3. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine;Pilishvili;J Infect Dis,2010
4. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children—Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and mortality weekly report 2010;59(9):258–61
5. Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization;Flannery;Ann Inter Med,2006
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献